COVID-19 Resources
FDA Limits Emergency Use Authorization for Johnson & Johnson Vaccine
The Food and Drug Administration (FDA) recently limited the authorized use of the Johnson & Johnson (J&J)/Janssen COVID-19 vaccine to people age 18 and older for whom other vaccines aren’t appropriate or accessible and those who opt for J&J because…
Study Finds a 7,000% Increase in Telehealth Utilization During Pandemic
According to a new report, telehealth usage grew more than 7,000% during the first year of the pandemic. This is the process of communicating with a doctor via an app, or a webcam and computer. FAIR Health’s annual report studies…
Moderna Requests FDA Vaccine Authorization for Children Under Age 6
On Thursday, April 28, 2022, Moderna announced that it is seeking emergency use authorization for its COVID-19 vaccine to be used among children ages 6 months to 5 years. The company will finish submitting data supporting its position to the…
Health Experts Warn COVID-19 Cases May Rise Due to New BA.2 Variant
COVID-19 cases have trended down in the United States since a peak of infections in January 2022, according to the Centers for Disease Control and Prevention (CDC). Now, health experts warn of a potential uptick of infections in the coming…
FDA Authorizes Fourth Pfizer and Moderna Vaccine Doses for Individuals Aged 50 and Older and Immunocompromised
On Tuesday, March 29, the Food and Drug Administration (FDA) authorized a second booster dose of two COVID-19 vaccines for people aged 50 and older and individuals who are immunocompromised. The new boosters could be administered four months after the…
Telehealth Coverage for HDHPs Extended
A spending bill signed into law on March 15, 2022, extends the ability of high-deductible health plans (HDHPs) to provide benefits for telehealth or other remote care services before plan deductibles have been met without jeopardizing health savings account (HSA)…